Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_3
1
20%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Completed(1)

Detailed Status

Not yet recruiting2
Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (20.0%)
Phase 31 (20.0%)
N/A3 (60.0%)

Trials by Status

completed120%
not_yet_recruiting240%
recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
recruitingnot_applicable

Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals.

NCT07505212
recruitingnot_applicable

TED_ORG: Study on Short Bowel Syndrome

NCT07400783
not_yet_recruitingnot_applicable

Effect of Oculomotor Therapy in Individuals With Convergence Insufficiency

NCT07036263
not_yet_recruitingphase_2

Extended LH Administration

NCT06883890
completedphase_3

Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia

NCT00797797

Clinical Trials (5)

Showing 5 of 5 trials
NCT07505212Not Applicable

Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals.

Recruiting
NCT07400783Not Applicable

TED_ORG: Study on Short Bowel Syndrome

Recruiting
NCT07036263Not Applicable

Effect of Oculomotor Therapy in Individuals With Convergence Insufficiency

Not Yet Recruiting
NCT06883890Phase 2

Extended LH Administration

Not Yet Recruiting
NCT00797797Phase 3

Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5